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Abstract 
Purpose: To assess the level of knowledge on warfarin therapy and anticoagulation control, and 
explore the association between knowledge and anticoagulation control in a section of Saudi population.  
Methods: A cross-sectional prospective survey was conducted over a 4-week period in 2013 at King 
Khalid University Hospital outpatient anticoagulant clinic in Riyadh, Saudi Arabia. Adult patients who 
were either discharged on warfarin or taking warfarin and attending the outpatient anticoagulant clinic 
for ≥ 6 months were invited to participate in the study. A questionnaire was used to collect the 
demographic data and knowledge of warfarin therapy (8-item). International Normalized Ratio (INR) 
readings were obtained from electronic-laboratory database. Good knowledge of warfarin was defined 
as a score of ≥ 75 % and good (INR) control was defined as ≥ 75 % Time INR in therapeutic range 
(TTR) calculated using Rosendaal method.  
Results: A total of 105 patients completed the questionnaire with a response rate of 49.2 %. Seventy-
nine patients (75.2 %) had good knowledge of warfarin (scored ≥ 75 %), but only 35 patients (33.3 %) 
had good anticoagulation control (TTR ≥ 75 %). An association was observed between patients with no 
formal education and poor warfarin knowledge (p = 0.012). Smoking history was also linked with 
warfarin knowledge (p = 0.025). INR control results significantly differed by marital status with 
divorced/widow status displaying poor INR control (p = 0.028). Lastly, no association was found 
between good knowledge and good INR control (OR 1.35, 95 %; CI 0.537 – 3.392). 
Conclusions: The majority of patients seen at the outpatient anticoagulation clinic have good 
knowledge of warfarin therapy although only a third showed good anticoagulation control. The results 
indicate no significant association between knowledge of warfarin therapy and anticoagulation control. 
Studies with a larger sample size are recommended to verify the foregoing results.  
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Warfarin is the most widely used anticoagulation 
drug worldwide including Saudi Arabia due to its 
ease of administration and low cost. The drug 
has a very low narrow therapeutic index and it 
provides effective anticoagulation for the 
treatment of thromboembolic conditions.  In the 
US, 31 million prescriptions were written in 2004 
for the treatment of these various 
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thromboembolic conditions [1]. Warfarin has a 
fair safety and a tolerability profile providing that 
INR levels are kept within therapeutic range. The 
target INR ranges are between 2.0 to 3.0 for 
most indications except for mitral valve 
replacement (2.5 to 3.5).  
 
The improper use of warfarin is associated with 
unintentional bleeding and thrombosis as well as 
the lack of patients' knowledge, concurrent 
disease states, diet, and poor adherence to 
warfarin therapy [2-4].  Warfarin-associated 
intracerebral hemorrhage [5], with a 50 % 
mortality rate, is one of the most severe adverse 
drug events (ADEs).  A 2007 Mayo Clinic study 
estimated that the number of warfarin-related 
ICH ADEs was 8,000 to 10,000 each year [6]. 
From January 1993 to June 2006, 10 % of 
warfarin-associated bleeding events reported to 
FDA’s Adverse Events Reporting System were 
fatal [1]. Unintended thromboembolic events 
have also been reported as a result of 
inadequate anticoagulation. In 2013, Chen et al 
reported that high-risk patients, who were not 
compliant with warfarin therapy, had risks which 
were three times greater of VTE recurrence [7].   
 
An association between patient knowledge of 
warfarin therapy, their demographic background, 
and therapeutic outcomes were also studied [2, 
8-10]. The survey by Huet et al found that high 
family income, a high level of education and self-
employed status were linked with high warfarin 
knowledge scores [8].  Barcellona et al studied 
the association between knowledge of warfarin 
and anticoagulation control in 219 patients using 
a 6-item knowledge questionnaire. The study 
suggested a positive relationship between good 
INR control and high warfarin knowledge scores 
[9].  A study from Qatar also showed a positive 
association between knowledge of warfarin and 
good INR control on patients who were taking the 
drug for various thromboembolic conditions [10].  
However, not all studies concur with such 
findings. Davis et al used an 18-question 
multiple-choice test to assess the association 
between patient demographic characteristics, 
knowledge of warfarin and anticoagulation 
control and results showed no positive 
associations [11]. 
 
The aim of this study is to assess the level of 
knowledge on warfarin therapy and 
anticoagulation control based on demographics 
and other characteristics and to explore 
association between knowledge and 
anticoagulation control in the Saudi population 
who have been prescribed warfarin.  
EXPERIMENTAL  
 
Patients and methods 
 
A cross-sectional prospective survey was 
conducted over a 4-week period in October to 
November 2013 at King Khalid University 
Hospital outpatient anticoagulant clinic. The 
hospital is a tertiary care hospital in Riyadh, 
Saudi Arabia with a 1000 inpatient bed capacity. 
It provides medical services to Saudi citizens 
from all over the Kingdom. The anticoagulant 
clinic offers follow-up services to all hospital-
discharged patients who are prescribed 
anticoagulants. All adult patients (≥ 16 years old) 
who were discharged from the hospital and who 
were expected to take warfarin and attend the 
outpatient anticoagulant clinic for ≥ 6 months 
were invited to participate in the study. Patients 
were excluded from the study if they had 
disruption in warfarin therapy for ≥ 5 days during 
the study period, were hospitalized during the 
study period for any reason, if they had an 
incomplete questionnaire or did not have four 
consecutive INR readings.  
 
Prior to conducting the study, approval from the 
Institutional Review Board (IRB) was obtained. 
The study objective was explained prior to 
interview, and written consent was obtained if the 
patient verbally agreed to participate. The 
questionnaire was administered face-to-face by 
trained researchers; they were monitored to 
ensure quality of research. 
 
The questionnaire comprised of three parts. The 
first part collected the patient demographic data 
including age, gender, educational level, 
occupation, and marital status. The second part 
of the questionnaire measured the knowledge 
using an 8-item survey questionnaire that was 
developed based on education and counseling of 
warfarin therapy provided to patients during their 
hospital discharge. The questions included food-
drug interactions; drug-drug interactions; the 
reasons for taking warfarin; actions to take in 
case of a missed dose or bleeding occurring 
while on warfarin; and the importance of notifying 
the use of warfarin to other health care providers 
during a visit to the anticoagulation clinic 
(Appendix 1).  The questionnaire also contained 
a few questions from previously validated survey 
by Briggs et al with some modifications. They 
were translated to Arabic according to 
international guidelines [12,13]. The 
questionnaire was administered in Arabic 
language using a multiple choice question 
format.  Each correct answer was given one 
point. Good knowledge was defined as a 
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knowledge questionnaire score of ≥ 75 % (6 out 
of 8 correct answers).  
 
Lastly, the third part assessed the level of INR 
control. To assess the anticoagulation control, 
the most recent consecutive four INR readings, 
on an average of 4 weeks apart were obtained 
from the hospital central laboratory electronic 
data system for each patient.  Anticoagulation 
control was defined as an INR that was between 
2 ≥ 3.0 for all indications except for mitral valve 
replacement, where anticoagulation control was 
defined as an INR within the range of 2.5 ≥ 3.5. 
Good INR control was defined as percent Time 
INR in Therapeutic Range (TTR) ≥ 75 % during 
study period using the Rosendaal method [14]. 
 
The questionnaire was validated in a crossover 
pilot study conducted on 20 patients who were at 
the time using warfarin.  In a private designated 
counseling area, the researchers administered 
the questionnaire to patients on two separate 
occasions that were 2 weeks apart to avoid 
duplication of responses. For internal 
consistency of the knowledge on all questions of 
the pilot study, Cronbach's alpha was calculated. 
The value was 0.71 with good reliability.  
 
The anticoagulation clinic used the hospital 
guideline adopted from the American College of 
Chest Physicians Evidence-Based Clinical 
Practice Guidelines (8th Edition) to adjust 




Descriptive statistics with counts and 
percentages were used to illustrate the results. 
Alongside this, Chi-square tests and Fisher’s 
exact test were used to detect if there were any 
associations between demographic 
characteristics, knowledge and anticoagulation 
control. A logistics analysis was used to detect 
any association among demographic 
background, knowledge and anticoagulation 
control.  A p-value of < 0.05 was considered as 
statically significant.  Statistical analyses were 
conducted using the Statistical Package for 
Social Science (SPSS) software, version 18.0 






A total of 232 patients attended the outpatient 
anticoagulation clinic during study period and out 
of this figure, 118 patients accepted to partake in 
the study which is a response rate of 49.2 %. It 
must be noted that 13 patients were excluded 
from the analysis due to the following reasons: 
incomplete INR results (3 patients), disruption in 
warfarin therapy (2 patients), and a substantial 
number of survey questions were not answered 
(8 patients). The demographic and other patient 
characteristics of the 105 patients are 
summarized in relation to their knowledge and 
level of anticoagulation control in Tables 1 and 2. 
 
The mean age of the study population was 55.4 
SD ± 15.3 years. Of the 105 participants, 69 
(65.7 %) were female, 71 (67.6 %) were aged 50 
and above, 84 (81.6 %) were non-smokers and 
76 (74.5 %) were married. Also, 40 (38.8 %) 
participants had not had any formal education 
and a low figure of 17 (16.5 %) had a university 
diploma.  Twenty-nine participants (27.6 %) 
stated to have a job and the remainder were 
unemployed.  The majority (61, 61.6 %) said they 
always attended the anticoagulation clinic without 
missing appointments and the remainder stated 
they could not always attend the clinic. The most 
common indications for warfarin therapy were 
deep vein thrombosis and pulmonary embolism 
(47, 48.0 %) followed by prosthetic heart valve 
(22, 22.4 %) and atrial fibrillation (11, 11.2 %). 
 
Anticoagulation control  
 
The mean ± SD INR values obtained for four 
readings were as follows: INR 1st reading 2.45, 
SD ±  0.88,  range 0.97 to 8.02;  INR 2nd reading 
2.57, SD ± 0.82, range 1.05 to 5.77; INR 3rd 
reading 2.70,  SD  ±  0.90, range 0.93 to 6.71, 
and 4th reading 2.79, SD ± 0.84, range 1.16 to 
6.71.  The mean INR follow-up days were 115 
SD ± 44.  Only 35 (33.3 %) participants had good 
anticoagulation control (TTR ≥ 75 %) during the 
study period.  Of the 70 participants with poor 
anticoagulation control (TTR < 75 %), 29 (41.4 
%) patients had INR values below the 
therapeutic range and 41 (58.6 %) had INR 
values above the therapeutic range.  Fisher’s 
exact test showed good INR control significantly 
differed by marital status with the divorced/widow 
status associated with poor INR control (p = 
0.028). 
 
Knowledge of warfarin therapy 
 
Seventy-nine (75.2 %) patients demonstrated 
good knowledge of warfarin (scored ≥ 75 %). 
Overall, 54 (51.4 %) patients scored 100 % on 
knowledge questions whereas only 12 (11.4 %) 




Trop J Pharm Res, July 2015; 14(7): 1288  
 
Table 1: Association between demographics plus other patient characteristics and anticoagulation control 
 






Gender (n=105)     
 
0.191** 
 Male 36 (34.3) 21 (58.3) 15 (41.7) 
 Female  69 (65.7) 49 (71.0) 20 (29.0) 
Marital status (n=102)     
 
0.028* 
 Married  76 (74.5) 50 (65.8) 26 (34.2) 
 Unmarried 11 (10.8) 5 (45.5) 6 (54.5) 
 Divorced/ widow 15 (14.7) 14 (93.3) 1 (6.7) 
Age group (n=105)     
 
0.998** 
 < 50  34 (32.4) 23 (67.5) 11 (32.5) 
 50 to 70  53 (50.5) 35 (66.0) 18 (34.0) 
 > 70  18 (17.1) 12 (66.7) 6 (33.3) 
Educational level (n=103)     
 
0.569** 
 No formal education  40 (38.8) 29 (72.5) 11 (27.5) 
 High/Middle school  46 (44.7) 30 (65.2) 16 (34.7) 
 Diploma/ University 17 (16.5) 10 (58.8) 7 (41.2) 
Occupation (n=98)     
 
0.731** 
 Employed 29 (29.6) 18 (62.1) 11 (37.9) 
 Unemployed 69 (70.4) 47 (68.1) 22 (31.9) 
Smoking history (n=103)     
 
0.923** 
 Non smoker  84 (81.6) 55 (65.5) 29 (34.5) 
 Smoker  18 (17.4) 12 (66.7) 6 (33.3) 
Reason for taking warfarin (n=98)     
 Atrial fibrillation 11 (11.2) 8 (72.7) 3 (27.3)  
 
0.672* 
 DVT/PE  47 (48.0) 31 (66.0) 16 (34.0) 
 Prosthetic heart valve  22 (22.4) 16 (72.7) 6 (27.3) 
 Others  18 (18.4) 12 (66.7) 6 (33.3) 
Clinic attendance (n=99)     
 
0.214** 
 Always attend clinic  61 (61.6) 44 (71.1) 17 (27.8) 
 Not always attend clinic 38 (38.4) 22 (57.9) 16 (42.1) 
DVT/PE: deep vein thrombosis/pulmonary embolism. *Fisher’s exact test. ** Chi square test 
 
The level of knowledge on warfarin therapy was 
only associated with education level and smoking 
status.  No formal education contributed to poor 
warfarin knowledge compared to other groups (p 
= 0.012).  Warfarin knowledge significantly 
differed by smoking status with non-smoking 
status being associated with poor knowledge (p 
= 0.028).No other link was found between 
warfarin knowledge and any other demographic 
characteristics (Table 2). 
 
Association between knowledge and 
anticoagulation control 
 
Seventy-nine (75.2 %) patients had good 
knowledge of warfarin (scored ≥ 75 %), but only 
35 (33.3 %) patients had good anticoagulation 
control (TTR ≥ 75 %). No association was found 
between good knowledge and good INR control 





This is the first study to investigate the 
knowledge of warfarin therapy and 
anticoagulation control (INR) based on patients’ 
demographic characteristics.  This study 
explored the association between knowledge and 
anticoagulation control within the Saudi 
population.  A third of the patients (33.3 %) at 
King Khalid University Hospital had good INR 
control. The results of good INR control from 
previously published studies in the literature 
range from 14 % to 48 %. The study by Davis et 
al showed that only 14 % of patients who were 
prescribed warfarin achieved good 
anticoagulation control, defined as more than 70 
% of INR values within therapeutic range [11].  
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Table 2: Association between demographic plus other characteristics and knowledge score 
 






Gender (105)     
 Male 36 (34.3) 6 (16.7) 30 (83.3) 0.165* 
 Female        69 (65.7) 2 (26.3) 49 (66.7) 
Marital status (102)     
 Married  76 (74.5) 17 (22.7) 59 (77.6) 0.649* 
 Unmarried 11 (10.8) 3 (27.3) 8 (72.7) 
 Divorced/widow  15 (14.7) 5 (33.3) 10 (67.7) 
Age group (105))     
 < 50  34 (32.4) 6 (17.6) 28 (82.4) 0.215* 
 50 to 70  53 (50.5) 17 (32.1) 36 (67.9) 
 > 70  18 (17.1) 3 (16.7) 15 (83.3) 
Educational level (103)     
 No formal education  40 (38.8) 16 (40.0) 24 (60.0) 0.012* 
 High/Middle school 46 (44.7) 7 (15.2) 39 (84.8) 
 Diploma/ University  17 (16.5) 2 (11.8) 15 (88.2) 
Occupation (98)     
0.292*  Employed 29 (29.6) 4 (13.8) 25 (86.2) 
 Unemployed 69 (70.4) 16 (23.2) 53 (76.8) 
Smoking history (102)     
 Non-smoker 84 (81.6) 25(29.8) 59 (70.2) 0.025* 
 Smoker 18 (17.4) 1 (5.6) 17 (94.4) 
Reason for taking warfarin 
(98) 
    
 Atrial fibrillation  11 (11.2) 4 (36.4) 7 (63.6) 0.335* 
 DVT/PE  47 (48.0) 10 (21.3) 37 (78.7) 
 Prosthetic heart valve  22 (22.4) 3 (13.6) 19 (86.4) 
 Other  18 (18.4) 2 (11.1) 16 (88.9) 
Clinic attendance      
 Always attend clinic  61 (61.6) 11 (18.0) 50 (82.0) 0.228** 
 Not always attend clinic 38 (38.4) 11 (28.9) 27 (71.1) 
DVT/PE: deep vein thrombosis/pulmonary embolism; * Fisher’s exact test; ** Chi square test 
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The study sample size was small with only 52 
participants and TTR percent was calculated on 
the INR result obtained only within 60 days prior 
to survey completion. The study by Khudair et al 
from Qatar showed that despite patients 
receiving education on warfarin therapy, only 68 
patients (48 %) achieved good anticoagulation 
control [10]. However, the most widely used 
Rosenadaal Method was not used to calculate 
TTR for INR control.  Likewise, the study by 
Kagansky et al showed that even after providing 
education on warfarin therapy to 323 elderly, only 
45.1 % achieved good anticoagulation control [4]. 
Good anticoagulation control was defined as INR 
values between 2 and 3 and not based on TTR.  
 
A number of factors can affect coagulation 
control whilst on warfarin therapy [16].  Genetic 
variation of disposing warfarin by the liver could 
potentially be a factor that contributes to poor 
anticoagulation in patients but this is unlikely 
within the Saudi population. The study conducted 
by Saour et al showed that the prevalence of the 
CYP2C9 polymorphism in the Saudi population is 
low (36 %) and is similar to that seen in 
Caucasians. Populations with high CYP2C9 
polymorphism require 40 % less warfarin and 
serious bleeds are more likely to occur with 
normal warfarin doses [17].  
 
It can be suggested that poor adherence to 
warfarin therapy may have contributed to poor 
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anticoagulation control in this study. Previous 
studies have shown that adherence to warfarin 
therapy is significantly associated with 
anticoagulation (INR) control [3,10,11]. It is 
recommended that future studies are required in 
order to examine such effect on the population.  
 
In this study, 79 patients (75 %) had good 
knowledge of warfarin. Baker et al has previously 
surveyed anticoagulation knowledge of patients 
receiving warfarin therapy in an outpatient 
anticoagulation clinic similar to the setting in this 
study, and used a validated 29-item anti-
coagulation knowledge assessment question-
naire. The results showed that 74.1 % of patients 
had good knowledge of warfarin (score ≥ 72.4 
%), which is comparable to the findings in this 
study [18]. However, the study from Qatar 
showed that only 78 patients (56 %) had 
satisfactory knowledge (score ≥ 75 %) of 
warfarin.  The study used a 12-item question-
naire similar to the current survey, although the 
demographic characteristics differed from the 
patients in this study [10]. There were more male 
participants (64 %) with various ethnic 
backgrounds [10]. 
 
This study did not find that good knowledge of 
warfarin therapy contributed to good INR control 
in patients.  Regardless of the fact that 75.2 % of 
patients had a good level of knowledge on 
warfarin therapy, only 33.3 % showed good INR 
control. Conflicting results have been reported in 
literature regarding the relationship between 
warfarin knowledge and anticoagulation control.  
Davis et al and the Newcastle Anticoagulation 
Study Group reported a lack of association 
between anticoagulation control and knowledge 
of warfarin therapy in their patients [11,19]. On 
the contrary, other researchers have reported a 
positive association between good knowledge of 
warfarin and good anticoagulation control 
[2,9,10,20]. 
 
Limitations of the study 
 
This study has a number of limitations that must 
be reported. The surveyors were unable to 
control patients' comorbid conditions and some 
other variables such as behavioral, social and 
physiologic factors that can affect anticoagulation 
control. The anticoagulation clinic used 
designated guidelines to adjust the warfarin dose 
for consistency [15]. Although the guidelines are 
provided at the clinic, the knowledge and 
attitudes of physicians regarding the use of 
warfarin in various conditions are varied which 
might affect anticoagulation [21]. The surveyors 
used same two researchers during the entire 
study to administer the questionnaire face to face 
instead of using a self-administered question-




This study demonstrates that a majority of 
patients seen at the outpatient anticoagulation 
clinic have good knowledge of warfarin therapy 
although many showed poor anticoagulation 
control.  No link was found between knowledge 
of warfarin therapy and anticoagulation control. 
Further studies are needed to examine whether 
there is an association between adequate 
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